Capricorn Systems Global Solutions Limited reported a net profit of ₹93.8 lakh for the quarter ended June 30, 2026 (Q1FY26), marking a 42% decline from the ₹160.4 lakh earned in the preceding quarter. The company’s revenue from operations contracted sharply by 50% quarter-on-quarter to ₹817.69 lakh, reflecting a substantial slowdown in its core agri-products trading business. This performance signals weakening operational momentum as the company navigates lower transaction volumes and persistent losses in its software division.

The Board of Directors approved the unaudited financial results on August 12, 2026, following a review by the Audit Committee. The figures were subjected to a limited review by the statutory auditors, S N M R & Associates, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3:00 p.m. IST and concluded at 4:00 p.m. IST.

Segment Performance

The company operates in two distinct segments: Software Development and Processing & Trading in Agri Products. The agri-products segment remains the primary profit driver, though it saw reduced activity compared to the prior quarter.

The Software Development segment reported a loss of ₹4.55 lakh, slightly improving from the ₹8.11 lakh loss recorded in the previous quarter. However, it continues to drag down overall profitability. In contrast, the Agri Products segment generated a profit of ₹17.06 lakh, down from ₹24.66 lakh in the earlier period, aligning with the broader revenue decline.

What the Numbers Show

A critical observation from the filing is the disproportionate reliance on the agri-products segment for profitability. While this segment contributed 97% of total revenue, the software development unit—despite contributing only 3% of revenue—accounted for a significant portion of the operational drag. Furthermore, the company noted an increase in employee benefit expenses due to new labour codes notified by the Ministry of Labour and Employment in November 2025. Although deemed immaterial for exceptional item disclosure in Q4FY26, management is evaluating further impacts on future quarters.

Key Financial Metrics

*Note: Year-over-year comparison shows massive growth from a negligible base of ₹26.51 lakh in Q1FY25.

The company also disclosed that the Scheme of Amalgamation of Radical Bio-Organics Limited with Capricorn Systems, approved on April 11, 2026, is pending regulatory approvals from SEBI, stock exchanges, shareholders, creditors, and the NCLT. The appointed date for the amalgamation is April 1, 2026.

Capricorn Systems Global , a company listed on the Bombay Stock Exchange (BSE: 512169), has announced a crucial meeting to determine the specifics of its upcoming rights issue. This development comes as part of the company's strategic financial planning, following the initial approval of the rights issue by the Board of Directors.

Key Meeting Details

The Rights Issue Committee of the Board of Directors is scheduled to convene on Thursday, October 16, 2025. This meeting will focus on finalizing several critical aspects of the rights issue:

Background

The decision to proceed with a rights issue was initially approved by the Board of Directors in a meeting held on Friday, October 10, 2025. This rights issue will involve fully paid-up equity shares with a face value of ₹10 each.

Significance for Shareholders

This rights issue is specifically targeted at eligible equity shareholders of Capricorn Systems Global. It presents an opportunity for existing shareholders to increase their stake in the company, potentially at a favorable price.

Company Information

Capricorn Systems Global is headquartered at H. No: 1-120/B/28, Plot No: 28, Siri Enclave Colony, Nizampet, Hyderabad - 500090. The company, with CIN L52510TG1985PLC043347, operates under the leadership of Managing Director Manmohan Rao Suddhala.

Market Impact

While the specific financial implications of this rights issue are yet to be determined, such corporate actions often have significant effects on a company's capital structure and shareholder value. Investors and market analysts will be keenly awaiting the outcome of the October 16 meeting for a clearer picture of the issue's terms and potential market impact.

Shareholders and potential investors are advised to stay informed about the upcoming announcements regarding the rights issue, as these details will be crucial for making informed investment decisions.